{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:28:06Z","timestamp":1790692086626,"version":"4.1.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>This article describes a child with a life-threatening multiorgan failure with disseminated intravascular coagulation (DIC) and massive complement consumption. To our knowledge this therapeutic approach was for the first time effectively applied in a pediatric patient.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 14-month-old boy was presented with a severe, rapidly progressing, life-threatening disease because of sudden onset of fever, hemathemesis, hematuria, and bloody diarrhoea alongside fast spreading hematomas and general corporeal edema.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>The most plausible diagnosis in our patient is <jats:italic toggle=\"yes\">Clostridium difficile<\/jats:italic> sepsis-induced thrombotic microangiopathy alongside with DIC and consumption coagulopathy. The diagnosis was confirmed by positive <jats:italic toggle=\"yes\">C difficile<\/jats:italic> bacteria strain in coproculture, clinical, and laboratory tests affirming DIC and global complement activation and consumption.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient was treated with antibiotics (Metronidazole, Vancomycin), plasmapheresis, dialysis, methylprednisolone, mycophenolate mofetil, and Eculizumab.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The child is in fair overall condition in a 2 year follow-up with no complications save chronic renal failure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>In rare cases of sepsis with massive complement consumption, a case-sensitive Eculizumab therapy may be at least considered after the resolution of life-threatening multiorgan failure. The application of this drug can be performed only after sepsis induced disease is put under control. A fast withdrawal of Eculizumab after control of massive complement consumption is recommended to prevent triggering of second sepsis reactivation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000014105","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T07:15:32Z","timestamp":1548400532000},"page":"e14105","source":"Crossref","is-referenced-by-count":15,"title":["A case report of a child with sepsis induced multiorgan failure and massive complement consumption treated with a short course of Eculizumab"],"prefix":"10.1097","volume":"98","author":[{"given":"Slobodan","family":"Galic","sequence":"first","affiliation":[{"name":"University Hospital Centre Zagreb, Kispaticeva, Zagreb"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorottya","family":"Csuka","sequence":"additional","affiliation":[{"name":"Research Laboratory, 3rd Department of Internal Medicine and MTA-SE Research Group of Immunology and Hematology, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Proh\u00e1szka","sequence":"additional","affiliation":[{"name":"Research Laboratory, 3rd Department of Internal Medicine and MTA-SE Research Group of Immunology and Hematology, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Turudic","sequence":"additional","affiliation":[{"name":"University Hospital Centre Zagreb, Kispaticeva, Zagreb"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Dzepina","sequence":"additional","affiliation":[{"name":"University Hospital Centre Zagreb, Kispaticeva, Zagreb"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danko","family":"Milosevic","sequence":"additional","affiliation":[{"name":"University Hospital Centre Zagreb, Kispaticeva, Zagreb"},{"name":"University of Zagreb, School of Medicine, Salata, Zagreb, Croatia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/jpids\/pis071","article-title":"Clostridium difficile infection in children: current state and unanswered questions","volume":"1","author":"Tamma","year":"2012","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11908-017-0603-8","article-title":"Recent issues in pediatric Clostridium difficile infection","volume":"19","author":"Clayton","year":"2017","journal-title":"Curr Infect Dis Rep"},{"key":"R3-20230914","first-page":"134","article-title":"Current treatment options for severe Clostridium difficile-associated disease","volume":"4","author":"Shen","year":"2008","journal-title":"Gastroenterol Hepatol (NY)"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2052-0492-2-15","article-title":"Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines","volume":"2","author":"Wada","year":"2014","journal-title":"J Intensive Care"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1186\/cc12783","article-title":"A multicenter, prospective validation study of the disseminated intravascular coagulation scoring system in patients with severe sepsis","volume":"17","author":"Gando","year":"2013","journal-title":"Crit Care"},{"key":"R6-20230914","first-page":"24","article-title":"BJH guideline","volume":"145","author":"Levi","year":"2009","journal-title":"Guidelines for the diagnosis and management of disseminated intravascular coagulation"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"302","DOI":"10.5414\/CN107691","article-title":"Hemolytic uremic syndrome associated with Clostridium difficile infection","volume":"81","author":"Alvarado","year":"2014","journal-title":"Clin Nephrol"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1016\/S0272-6386(03)00210-5","article-title":"Clostridium difficile colitis associated with hemolytic-uremic syndrome","volume":"41","author":"Mbonu","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R9-20230914","first-page":"586","article-title":"Atypical hemolytic uremic syndrome associated with Clostridium difficile infection and partial membrane cofactor protein (CD46) deficiency","volume":"14","author":"Kalmanovich","year":"2012","journal-title":"IMAJ"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"109","DOI":"10.12659\/AJCR.892907","article-title":"Atypical hemolytic-uremic syndrome: a case report and literature review","volume":"16","author":"Rafiq","year":"2015","journal-title":"Am J Case Rep"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40560-014-0061-4","article-title":"Complement, thrombotic microangiopathy and disseminated intravascular coagulation","volume":"2","author":"Kurosawa","year":"2014","journal-title":"J Intensive Care"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/MD.0000000000006056","article-title":"Complement-mediated thrombotic microangiopathy secondary to sepsis-induced disseminated intravascular coagulation successfully treated with eculizumab","volume":"96","author":"Abe","year":"2017","journal-title":"Medicine"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MD.0000000000004104","article-title":"Complete remission of thrombotic microangiopathy after treatment with eculizumab in a patient with non-Shiga toxin associated bacterial enteritis","volume":"95","author":"Omura","year":"2016","journal-title":"Medicine"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/1471-2369-14-260","article-title":"Renal thrombotic microangiopathy in a patient with septic disseminated intravascular coagulation","volume":"14","author":"Sakamaki","year":"2013","journal-title":"BMC Nephrol"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ajh.22091","article-title":"Systemic infections mimicking thrombotic thrombocytopenic purpura","volume":"86","author":"Booth","year":"2011","journal-title":"Am J Hematol"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s00134-003-1676-4","article-title":"Infectious diseases as a trigger in thrombotic microangiopathies in intensive care unit (ICU) patients?","volume":"29","author":"Coppo","year":"2003","journal-title":"Intensive Care Med"},{"key":"R17-20230914","first-page":"47","article-title":"Infection frequently triggers thrombotic microangiopathy in patients with preexisting risk factors: a single-institution experience","volume":"25","author":"Douglas","year":"2010","journal-title":"J Clin Apher"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.thromres.2011.10.011","article-title":"Plasma ADAMTS 13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases","volume":"129","author":"Habe","year":"2012","journal-title":"Thromb Res"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2005-03-1087","article-title":"Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS 13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure","volume":"107","author":"Ono","year":"2006","journal-title":"Blood"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.nefro.2017.01.006","article-title":"Secondary thrombotic microangiopathy and eculizumab: a reasonable therapeutic option","volume":"37","author":"Rom\u00e1n","year":"2017","journal-title":"Nefrologia"},{"issue":"(0 1)","key":"R21-20230914","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.thromres.2014.03.014","article-title":"Crosstalk between the coagulation and complement systems in sepsis","volume":"133","author":"Lupu","year":"2014","journal-title":"Thromb Res"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fimmu.2015.00215","article-title":"Complement-coagulation cross-talk: a potential mediator of the physiological activation of complement by low pH","volume":"6","author":"Kenawy","year":"2015","journal-title":"Front Immunol"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00281-011-0280-x","article-title":"Interactions between coagulation and complement\u2014their role in inflammation","volume":"34","author":"Oikonomopoulou","year":"2012","journal-title":"Semin Immunopathol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201901250-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T18:30:05Z","timestamp":1694716205000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201901250-00020"}},"subtitle":["A case of crosstalk between coagulation and complement?"],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014105","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}